| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| C U Correll, Ofer Agid, Benedicto Crespo-Facorro, Andrea de Bartolomeis, Andrea Fagiolini, Niko Seppälä, Oliver D Howe. Correction: A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant Schizophrenia. CNS drugs. 2022-08-17. PMID:35976566. |
correction: a guideline and checklist for initiating and managing clozapine treatment in patients with treatment-resistant schizophrenia. |
2022-08-17 |
2023-08-14 |
Not clear |
| Leeba Rezaie, Azadeh Nazari, Habibolah Khazai. Exploration of the Barriers to Clozapine Prescribing in Patients with Treatment-Resistant Schizophrenia: A Qualitative Study. Journal of psychosocial rehabilitation and mental health. 2022-08-15. PMID:35967884. |
exploration of the barriers to clozapine prescribing in patients with treatment-resistant schizophrenia: a qualitative study. |
2022-08-15 |
2023-08-14 |
human |
| Andrea de Bartolomeis, Annarita Barone, Licia Vellucci, Benedetta Mazza, Mark C Austin, Felice Iasevoli, Mariateresa Ciccarell. Linking Inflammation, Aberrant Glutamate-Dopamine Interaction, and Post-synaptic Changes: Translational Relevance for Schizophrenia and Antipsychotic Treatment: a Systematic Review. Molecular neurobiology. 2022-08-13. PMID:35963926. |
finally, the link between altered inflammatory/immune responses raises relevant questions regarding potential new therapeutic strategies specifically for those forms of schizophrenia that are resistant to canonical antipsychotics or unresponsive to clozapine. |
2022-08-13 |
2023-08-14 |
Not clear |
| Leeba Rezaie, Azadeh Nazari, Roya Safari-Faramani, Shamarina Shohaimi, Habibolah Khazai. Iranian psychiatrists' attitude towards clozapine use for patients with treatment-resistant schizophrenia: a nationwide survey. BMC psychiatry. vol 22. issue 1. 2022-08-06. PMID:35933353. |
iranian psychiatrists' attitude towards clozapine use for patients with treatment-resistant schizophrenia: a nationwide survey. |
2022-08-06 |
2023-08-14 |
Not clear |
| Nazanin Vaziri, Diogo Marques, Xuemei Wang, Pranav Machiraju, Ankita Narang, Katerina Vlahos, Christos Pantelis, Steven C Greenway, Chad A Bousma. Generation of two human induced pluripotent stem cell lines from peripheral blood mononuclear cells of clozapine-tolerant and clozapine-induced myocarditis patients with treatment-resistant schizophrenia. Stem cell research. vol 63. 2022-08-02. PMID:35917601. |
clozapine has superior efficacy in the treatment of refractory schizophrenia; however, use of clozapine is limited due to severe side effects, including myocarditis. |
2022-08-02 |
2023-08-14 |
human |
| Yu Funahashi, Yuta Yoshino, Jun-Ichi Iga, Shu-Ichi Uen. Impact of clozapine on the expression of miR-675-3p in plasma exosomes derived from patients with schizophrenia. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry. 2022-07-29. PMID:35904423. |
impact of clozapine on the expression of mir-675-3p in plasma exosomes derived from patients with schizophrenia. |
2022-07-29 |
2023-08-14 |
Not clear |
| Yu Funahashi, Yuta Yoshino, Jun-Ichi Iga, Shu-Ichi Uen. Impact of clozapine on the expression of miR-675-3p in plasma exosomes derived from patients with schizophrenia. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry. 2022-07-29. PMID:35904423. |
the aim of this study was to investigate the global expression changes of mirna derived from the plasma exo of patients with treatment-resistant schizophrenia (trs) and the effects of clozapine on mirna expression. |
2022-07-29 |
2023-08-14 |
Not clear |
| Maria Skokou, Eleni A Karavia, Zoi Drakou, Vassiliki Konstantinopoulou, Christina-Anna Kavakioti, Philippos Gourzis, Kyriakos E Kypreos, Ourania Andreopoulo. Adverse Drug Reactions in Relation to Clozapine Plasma Levels: A Systematic Review. Pharmaceuticals (Basel, Switzerland). vol 15. issue 7. 2022-07-27. PMID:35890117. |
clozapine is the gold standard for treatment-resistant schizophrenia. |
2022-07-27 |
2023-08-14 |
Not clear |
| Lara Moreno-Sancho, Maria Juncal-Ruiz, Javier Vázquez-Bourgon, Victor Ortiz-Garcia de la Foz, Jacqueline Mayoral-van Son, Diana Tordesillas-Gutierrez, Esther Setien-Suero, Rosa Ayesa-Arriola, Benedicto Crespo-Facorr. Naturalistic study on the use of clozapine in the early phases of non-affective psychosis: A 10-year follow-up study in the PAFIP-10 cohort. Journal of psychiatric research. vol 153. 2022-07-25. PMID:35878537. |
clozapine is seldom prescribed in treatment-resistant schizophrenia (trs) patients during early phases of the illness. |
2022-07-25 |
2023-08-14 |
human |
| Lara Moreno-Sancho, Maria Juncal-Ruiz, Javier Vázquez-Bourgon, Victor Ortiz-Garcia de la Foz, Jacqueline Mayoral-van Son, Diana Tordesillas-Gutierrez, Esther Setien-Suero, Rosa Ayesa-Arriola, Benedicto Crespo-Facorr. Naturalistic study on the use of clozapine in the early phases of non-affective psychosis: A 10-year follow-up study in the PAFIP-10 cohort. Journal of psychiatric research. vol 153. 2022-07-25. PMID:35878537. |
our findings reinforce the need of a timely assessment of treatment-resistant criteria in early schizophrenia patients and highlight the long-term benefits of an early introduction of clozapine on those patients meeting treatment-resistant criteria. |
2022-07-25 |
2023-08-14 |
human |
| Gregg Alan Robbins-Welty, Shannon Coats, Andrew N Tuck, Bryan K Lao, Zachary Lan. Pulmonary Embolism during a Retrial of Low-dose Clozapine. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology. vol 20. issue 3. 2022-07-25. PMID:35879043. |
we present a case of a 34-year-old with treatment-refractory schizophrenia who developed rhabdomyolysis during his first clozapine trial. |
2022-07-25 |
2023-08-14 |
Not clear |
| Juan D Duque-Yemail, Juan Carlos Avil. Switching Clozapine to Cariprazine in Three Patients with Persistent Symptoms of Schizophrenia: A Case Series. Neuropsychiatric disease and treatment. vol 18. 2022-07-21. PMID:35859803. |
switching clozapine to cariprazine in three patients with persistent symptoms of schizophrenia: a case series. |
2022-07-21 |
2023-08-14 |
Not clear |
| Juan D Duque-Yemail, Juan Carlos Avil. Switching Clozapine to Cariprazine in Three Patients with Persistent Symptoms of Schizophrenia: A Case Series. Neuropsychiatric disease and treatment. vol 18. 2022-07-21. PMID:35859803. |
clozapine has shown efficacy in treating schizophrenia patients who failed to respond to previous antipsychotics. |
2022-07-21 |
2023-08-14 |
Not clear |
| Marte Z van der Horst, Georgia Papadimitriou, Jurjen J Luyk. Genetic determinants associated with response to clozapine in schizophrenia: an umbrella review. Psychiatric genetics. 2022-07-20. PMID:35855515. |
genetic determinants associated with response to clozapine in schizophrenia: an umbrella review. |
2022-07-20 |
2023-08-14 |
Not clear |
| Erica Neill, Susan L Rossell, Caitlin Yolland, Denny Meyer, Cherrie Galletly, Anthony Harris, Dan Siskind, Michael Berk, Kiymet Bozaoglu, Frances Dark, Olivia M Dean, Paul S Francis, Dennis Liu, Andrea Phillipou, Jerome Sarris, David J Castl. N-Acetylcysteine (NAC) in Schizophrenia Resistant to Clozapine: A Double-Blind, Randomized, Placebo-Controlled Trial Targeting Negative Symptoms. Schizophrenia bulletin. 2022-07-20. PMID:35857752. |
n-acetylcysteine (nac) in schizophrenia resistant to clozapine: a double-blind, randomized, placebo-controlled trial targeting negative symptoms. |
2022-07-20 |
2023-08-14 |
Not clear |
| Estela Sangüesa, Christine Cirujeda, Julia Concha, Pedro Pablo Padilla, Cristina Belén García, María Pilar Ribat. Pharmacokinetic interactions between clozapine and valproic acid in patients with treatment-resistant schizophrenia: Does UGT polymorphism affect these drug interactions? Chemico-biological interactions. 2022-07-19. PMID:35853541. |
pharmacokinetic interactions between clozapine and valproic acid in patients with treatment-resistant schizophrenia: does ugt polymorphism affect these drug interactions? |
2022-07-19 |
2023-08-14 |
Not clear |
| Estela Sangüesa, Christine Cirujeda, Julia Concha, Pedro Pablo Padilla, Cristina Belén García, María Pilar Ribat. Pharmacokinetic interactions between clozapine and valproic acid in patients with treatment-resistant schizophrenia: Does UGT polymorphism affect these drug interactions? Chemico-biological interactions. 2022-07-19. PMID:35853541. |
the combination of valproic acid (vpa) and clozapine (clz) is regularly prescribed for augmentation therapy in treatment resistant schizophrenia. |
2022-07-19 |
2023-08-14 |
Not clear |
| Sukhpreet Poonia, Mazen Sharaf, Ric M Procyshyn, Randal White, Reza Rafizade. Amisulpride Augmentation of Clozapine in Clozapine-Resistant Schizophrenia: A Case Series. The Canadian journal of hospital pharmacy. vol 75. issue 3. 2022-07-18. PMID:35847467. |
amisulpride augmentation of clozapine in clozapine-resistant schizophrenia: a case series. |
2022-07-18 |
2023-08-14 |
Not clear |
| Nicole M McGrath, Verity Humberstone, Ashley C Abraha. Diabetes mellitus prevalence in Northland New Zealand schizophrenia patients on clozapine. The New Zealand medical journal. vol 135. issue 1558. 2022-07-14. PMID:35834832. |
diabetes mellitus prevalence in northland new zealand schizophrenia patients on clozapine. |
2022-07-14 |
2023-08-14 |
Not clear |
| Nicole M McGrath, Verity Humberstone, Ashley C Abraha. Diabetes mellitus prevalence in Northland New Zealand schizophrenia patients on clozapine. The New Zealand medical journal. vol 135. issue 1558. 2022-07-14. PMID:35834832. |
clozapine is a unique atypical anti-psychotic agent with best efficacy for treatment resistant schizophrenia compared to other agents, but with increased metabolic adverse effects. |
2022-07-14 |
2023-08-14 |
Not clear |